MK0893

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0893, covering 2011-11-11 to 2012-05-08. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) [Phase 1]